Evidence map›Paper›PMID 38911725›Full record

ArticleACS omega2024

Structural Characterization, Spectroscopic Profile, Molecular Docking, ADMET Properties, Molecular Dynamics Simulation Studies, and Molecular Mechanics Generalized Born Surface Area Analysis of 5-(Adamantan-1-yl)-4-butyl-2,4-dihydro-3

Lamya H Al-Wahaibi, Ali A El-Emam, Mohammed S M Abdelbaky, Santiago Garcia-Granda, Anushree Maurya, Mamta Pal, Zohra Siddiqui, Raj Shukla, Shilendra K Pathak, Ruchi Srivastava and 3 more

Abstract read
In one paragraph

Article in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Lamya H Al-WahaibiDepartment of Chemistry, College of Sciences, Princess Nourah bint Abdulrahman University, Riyadh 11671, Saudi Arabia.
Ali A El-EmamDepartment of Medicinal Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt.ORCID https://orcid.org/0000-0002-9325-9497
Mohammed S M AbdelbakyDepartment of Physical and Analytical Chemistry, Faculty of Chemistry, Oviedo University-CINN, Oviedo 33006, Spain.ORCID https://orcid.org/0000-0001-8395-8705
Santiago Garcia-GrandaDepartment of Physical and Analytical Chemistry, Faculty of Chemistry, Oviedo University-CINN, Oviedo 33006, Spain.ORCID https://orcid.org/0000-0002-2373-0247
Anushree MauryaDepartment of Physics, University of Lucknow, Lucknow 226007, Uttar Pradesh, India.
Mamta PalDepartment of Physics, University of Lucknow, Lucknow 226007, Uttar Pradesh, India.
Zohra SiddiquiDepartment of Physics, University of Lucknow, Lucknow 226007, Uttar Pradesh, India.
Raj ShuklaDepartment of Physics, University of Lucknow, Lucknow 226007, Uttar Pradesh, India.
Shilendra K PathakDepartment of Physics, M. M. M. P. G. College, Deoria 274502, Uttar Pradesh, India.
Ruchi SrivastavaDepartment of Physics, University of Lucknow, Lucknow 226007, Uttar Pradesh, India.
Vikas K ShuklaDepartment of Physics, Maharishi University of Information Technology, Lucknow 226013, Uttar Pradesh, India.
Onkar PrasadDepartment of Physics, University of Lucknow, Lucknow 226007, Uttar Pradesh, India.
Leena SinhaDepartment of Physics, University of Lucknow, Lucknow 226007, Uttar Pradesh, India.ORCID https://orcid.org/0000-0003-3624-4085

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Employing a synergistic combination of theoretical density functional theory (DFT) and experimental techniques, we conducted a comprehensive analysis elucidating the structural and pharmacological attributes of 5-(adamantan-1-yl)-4-butyl-2,4-dihydro-3

Identifiers

PMID38911725
PMCPMC11191079

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.